PT  - JOURNAL ARTICLE
AU  - Vetter, Valentin Max
AU  - Sommerer, Yasmine
AU  - Kalies, Christian Humberto
AU  - Spira, Dominik
AU  - Bertram, Lars
AU  - Demuth, Ilja
TI  - Vitamin D Supplementation is Associated with Slower Epigenetic Aging
AID  - 10.1101/2021.12.10.21267597
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.12.10.21267597
4099  - http://medrxiv.org/content/early/2021/12/11/2021.12.10.21267597.short
4100  - http://medrxiv.org/content/early/2021/12/11/2021.12.10.21267597.full
AB  - Adverse effects of low vitamin D level on mortality and morbidity are controversially discussed. Especially older people are at risk for vitamin D deficiency and therefore exposed to its potentially harmful influence on the aging process. A way of measuring differences in the biological age is through DNA methylation age (DNAm age) and its deviation from chronological age, DNAm age acceleration (DNAmAA). We previously reported on an association between vitamin D deficiency and higher 7-CpG DNAmAA in participants of the Berlin Aging Study II (BASE-II).In this study, we employ a quasi-interventional study design to assess the relationship between DNAmAA of five epigenetic clocks and vitamin D supplementation. Longitudinal data were available for 1,036 participants of BASE-II that were reexamined on average 7.4 years later in the GendAge study (mean age at follow-up: 75.6 years, SD = 3.8 years, age range: 64.9 – 94.1 years, 51.9 % female). DNAmAA was estimated with the 7-CpG clock, Horvath’s clock, Hannum’s clock, PhenoAge and GrimAge. Methylation data were obtained through methylation-sensitive single nucleotide primer extension (MS-SNuPE) or Illumina’s Infinium “MethylationEPIC” array.Vitamin D deficient participants who chose to start vitamin D supplementation after baseline examination showed a 2.6 year lower 7-CpG DNAmAA (p=0.011) and 1.3-year lower Horvath DNAmAA (p=0.042) compared to untreated and vitamin D deficient participants. DNAmAA did not statistically differ between participants with successfully treated vitamin D deficiency and healthy controls (p>0.16).Therefore, we conclude that intake of vitamin D supplement is associated with lower DNAmAA in participants with vitamin D deficiency. Additionally, our findings suggest that sufficient vitamin D supplementation can compensate and potentially reverse the increase in 7-CpG DNAmAA that we found in in vitamin D deficient participants.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by grants of the Deutsche Forschungsgemeinschaft (grant number DE 842/7-1 to ID), the ERC (as part of the "Lifebrain" project to LB), and the Cure Alzheimer's Fund (as part of the "CIRCUITS" consortium to LB). This article uses data from the Berlin Aging Study II (BASE-II) and the GendAge study which were supported by the German Federal Ministry of Education and Research under grant numbers #01UW0808; #16SV5536K, #16SV5537, #16SV5538, #16SV5837, #01GL1716A and #01GL1716B.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The medical assessments at baseline and follow-up were approved by the Ethics Committee of the Charite - Universitaetsmedizin Berlin (approval numbers EA2/029/09 and EA2/144/16).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available upon reasonable request. Interested investigators are invited to contact the study coordinating PI Ilja Demuth at ilja.demuth{at}charite.de to obtain additional information about the GendAge study and the data-sharing application form.